Global Pediatric Vaccines Market:
There has been constant research for the development of novel molecules providing immunity against fatal diseases such as Zika virus and different types of cancers. For instance, in June 2016, Inovio Pharmaceuticals, Inc. stated the commencement of phase I clinical trial for their Zika DNA vaccine named GLS-5700. The vaccines administered to prevent children from several non-infectious and infectious diseases are known as pediatric vaccines. These vaccines are heat-killed or inactivated viruses that lose their pathogenicity, i.e., the ability to cause a disease.
Get Exclusive Free Sample Copy at https://www.marketresearchfuture.com/sample_request/5779
Moreover, these inactivated antigens can stimulate the immune system to produce antibodies against the infected virus. Thus, they assist the immune system in protecting itself from infectious or non-infectious diseases in the future. Currently, immunization prevents an estimated 2-3 million deaths every year. Furthermore, about 1.5 million deaths can be prevented through improved global coverage for vaccination.
The Worldwide Pediatric Vaccines Market is expected to grow at a CAGR of ~10.6% during 2017 to 2023. There are different pediatric vaccines accessible in the market, for example, pneumococcal immunization, polio antibody, rotavirus immunization, MMR immunization, flu immunization, hepatitis B antibody, meningococcal immunization, and Hib antibody.
However, low accessibility to remote areas, increasing availability of biosimilars at low rates, increasing cost of vaccines, limited or no access to healthcare services in developing and under-developed countries, low healthcare spending, and less medical coverage for pediatric vaccination are some of the challenges which might hamper the growth of the global pediatric vaccines market in future.
Some of the key players in the global pediatric vaccines market are GlaxoSmithKline plc (U.K.), Pfizer, Inc. (U.S.), Merck & Co., Inc. (U.S.), Sanofi Pasteur SA (France), Astellas Pharma Inc. (Japan), CSL Limited (Australia), Emergent BioSolutions, Inc. (U.S.), Johnson & Johnson (U.S.), MedImmune, LLC (U.S.), Serum Institute of India Pvt. Ltd. (India), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), Daiichi Sankyo (Japan), Protein Sciences Corporation (U.S.), Grifols (Spain), Crucell (Netherlands), Bharat Biotech (India), Kaketsuken (U.S.), Panacea Biotec (India), Baxter International (U.S.), Zydus Cadila (India), Nuron (U.S.), S K Chemicals (South Korea), Dynavax Technologies (U.S.), Bharat Immunologicals and Biologicals (India), Lupin Pharmaceuticals, Inc. (India), Indian Immunologicals (India), Novartis AG (Switerzland), LG Life Sciences (India), Shenzhen Kangtai Biological Products (China), Sinovac Biotech (China), Bio Med (India), AstraZeneca (UK), bioCSL Inc. (U.S.), Valeant Pharmaceuticals (U.S.), Takeda Pharmaceutical (Japan) and others.
The Global Pediatric Vaccines Market has been segmented on the basis of type, technology, disease indication, and route of administration. On the basis of type, the global pediatric vaccines market is segmented into monovalent vaccines, multivalent vaccines, and others.
On the basis of technology, the global pediatric vaccines market is segmented into synthetic vaccines, dendritic cells vaccines, conjugate vaccines, inactivated and subunit vaccines, live attenuated vaccines, toxoid vaccines, recombinant vaccines, and others.
On the basis of disease indication, the global pediatric vaccines market is segmented into MMR (Measles, Mumps, and Rubella), polio, Haemophilus influenza type B, pneumococcal disease, meningococcal disease, influenza, DTP (Diphtheria, Tetanus, Pertussis), hepatitis, varicella, rotavirus, combination vaccines and others. On the basis of route of administration, the global pediatric vaccines market is segmented into intramuscular administration, subcutaneous administration, oral administration, and other routes of administration
Pediatric Vaccines Market Regional Analysis:
The Global Pediatric Vaccines Market consists of four regions such as the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas region accounted for the largest market share of the global pediatric vaccines market owing to the growing initiatives by the U.S. Department of Health and Human Services (HHS) to reduce the occurrence rate of infectious diseases. Such factors along with the growing immunization will fuel the U.S. market.
The European pediatric vaccines market is urged due to the superior government spending such as NHS (Nation Healthcare Service) for the development of the pharmaceutical and medical industries. The Asia Pacific region is expected to grow rapidly during the forecast period owing to the growing healthcare sector in leading regions such as China and India. The Middle Eastern region is expected to grow at a steady pace owing to factors such as rising R&D activities in the healthcare sector and extensive development of healthcare infrastructure.
Get More Details at https://www.reuters.com/brandfeatures/venture-capital/article?id=132366
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028